FOXP4 and COVID-19: Previous studies have shown an association of FOX4 with an increased susceptibility to severe COVID-19 (135); despite the heightened risk of long COVID associated with severe COVID-19, this study suggested that the contribution of the FOXP4 rs9367106 polymorphism to the risk of LC was substantial and could not be only due to its association with severe COVID-19.